PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAF8R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $79,348
Award facts
- Contract value 100% obligated
- $79,347.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $79,347.60 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under Amerisourcebergen's parent company, Cencora, Inc. (doing business as Amerisourcebergen). The delivery order falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The contract demonstrates Amerisourcebergen's continued role as a critical vendor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Through this IDC vehicle and associated delivery orders, the company supplies essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains including diabetes management, neurological treatments, pain management, and antibiotics. The award reflects the company's capability to meet federal procurement requirements on an open and competitive basis and its established position within the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2D826FAF8R?
SPE2D826FAF8R was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826FAF8R worth?
The government has obligated $79,348 on SPE2D826FAF8R.
Is contract SPE2D826FAF8R an order under another contract?
Yes. SPE2D826FAF8R is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAF8R competed?
The extent of competition for SPE2D826FAF8R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award